DongKook Pharmaceutical Co. Ltd (086450) - Total Liabilities

Latest as of March 2026: ₩310.75 Billion KRW ≈ $210.59 Million USD

Based on the latest financial reports, DongKook Pharmaceutical Co. Ltd (086450) has total liabilities worth ₩310.75 Billion KRW (≈ $210.59 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

DongKook Pharmaceutical Co. Ltd - Total Liabilities Trend (2013–2025)

This chart illustrates how DongKook Pharmaceutical Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. See 086450 working capital ratio to evaluate short-term liquidity relative to the company's equity base.

DongKook Pharmaceutical Co. Ltd Competitors by Total Liabilities

The table below lists competitors of DongKook Pharmaceutical Co. Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Global Fashion Group S.A F:GFG	Germany	€353.40 Million
FELIX Gold Ltd AU:FXG	Australia	AU$1.22 Million
Zeotech Ltd AU:ZEO	Australia	AU$1.12 Million
Twinhead International Corp TW:2364	Taiwan	NT$1.00 Billion
Pang Rim Spinn KO:003610	Korea	₩71.68 Billion
SLOMAN NEPTUN Schiffahrts-Aktiengesellschaft HM:NEP	Germany	€94.77 Million
Sagittarius Life Science TWO:3205	Taiwan	NT$26.91 Million
Gandhi Special Tubes Limited NSE:GANDHITUBE	India	Rs241.06 Million

Liability Composition Analysis (2013–2025)

This chart breaks down DongKook Pharmaceutical Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 086450 company net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.06	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.46	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.28	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how DongKook Pharmaceutical Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for DongKook Pharmaceutical Co. Ltd (2013–2025)

The table below shows the annual total liabilities of DongKook Pharmaceutical Co. Ltd from 2013 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩299.16 Billion ≈ $202.73 Million	+9.11%
2024-12-31	₩274.19 Billion ≈ $185.81 Million	+4.11%
2023-12-31	₩263.36 Billion ≈ $178.48 Million	-1.14%
2022-12-31	₩266.39 Billion ≈ $180.53 Million	-9.85%
2021-12-31	₩295.51 Billion ≈ $200.26 Million	+17.36%
2020-12-31	₩251.80 Billion ≈ $170.64 Million	+38.72%
2019-12-31	₩181.51 Billion ≈ $123.01 Million	+8.54%
2018-12-31	₩167.22 Billion ≈ $113.32 Million	+52.90%
2017-12-31	₩109.37 Billion ≈ $74.12 Million	+24.59%
2016-12-31	₩87.78 Billion ≈ $59.49 Million	+16.76%
2015-12-31	₩75.18 Billion ≈ $50.95 Million	+11.21%
2014-12-31	₩67.60 Billion ≈ $45.81 Million	+20.68%
2013-12-31	₩56.02 Billion ≈ $37.96 Million	--

About DongKook Pharmaceutical Co. Ltd

KQ:086450 Korea Pharmaceuticals

Market Cap

$112.04 Million

₩165.33 Billion KRW

Market Cap Rank

#18848 Global

#888 in Korea

Share Price

₩18810.00

Change (1 day)

-4.52%

52-Week Range

₩16420.00 - ₩29900.00

All Time High

₩31498.93